I am in a clinical Jansen trial at UCLA which included lupron ( old and typical ADT. Treatment ) and Erleada which is the Jansen Apalutamide. There were manageable side effects but the drugs worked good for me. Studies that I have read stated that the Apalutamide men in the trial on an average avoided the cancer progression by 24 months over the men that got the procebo. I was on the meds for 13 months with a RP mid way through. I am off of the drugs now and they are checking me every 3 months. I feel very fortunate that I got in the clinical trial and my doctors have increased my livable prognosis.